Dolly Vance

Executive Vice President, Corporate Affairs and General Counsel

Analyst — Senior Advisor, Legal & Corporate Affairs

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2020	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President, Corporate Affairs, General	$524,890	—	—	$459,869	$200,770	$9,054	$1,194,583
2019	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President, Corporate Affairs, General	$514,598	—	—	$420,682	$239,288	$7,394	$1,181,962
2018	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President, Corporate Affairs, General	$504,508	—	—	$863,124	$401,402	$1,794	$1,770,828

Executive changes

Retired general counsel, executive vice president, corporate affairs, and corporate secretary at Rigel Pharmaceuticals Inc (RIGL)
2022-10-11

Earnings-call appearances

Rigel Pharmaceuticals Inc Q3 FY2022 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2022-11-03
Rigel Pharmaceuticals Inc Q2 FY2022 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2022-08-02
Rigel Pharmaceuticals Inc Q1 FY2022 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2022-05-03
Rigel Pharmaceuticals Inc Q4 FY2021 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2022-01-10
Rigel Pharmaceuticals Inc Q3 FY2021 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2021-11-02
Rigel Pharmaceuticals Inc Q2 FY2021 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2021-08-03
Rigel Pharmaceuticals Inc Q1 FY2021 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2021-05-05
Rigel Pharmaceuticals Inc Q4 FY2020 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2021-01-11
Rigel Pharmaceuticals Inc Q3 FY2020 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2020-11-05
Rigel Pharmaceuticals Inc Q2 FY2020 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2020-08-04
Rigel Pharmaceuticals Inc Q1 FY2020 Earnings Call
Rigel Pharmaceuticals Inc (RIGL)

2020-05-05